20 results
8-K
EX-99.1
SGMT
Sagimet Biosciences Inc.
14 Feb 25
Other Events
4:15pm
for R&D of FluMist , first innovation in flu vaccines in 60+ years Eduardo Martins CMO20 years of leadership of large - scale multinational clinical
8-K
EX-99.1
SGMT
Sagimet Biosciences Inc.
2 Jan 25
Other Events
8:00am
innovation in flu vaccines in 60+ years Eduardo Martins CMO20 years of leadership of large - scale multinational clinical trials & global teams
8-K
EX-99.2
SGMT
Sagimet Biosciences Inc.
14 Aug 24
Sagimet Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
8:06am
innovation in flu vaccines in 60+ years Eduardo Martins CMO20 years of leadership of large - scale multinational clinical trials & global teams in pharma
8-K
EX-99.1
SGMT
Sagimet Biosciences Inc.
2 Jul 24
Other Events
5:26pm
to the market George Kemble Executive Chairman20 years of experience in R&D in biotech and pharma Responsible for R&D of FluMist , first innovation in flu
DEF 14A
SGMT
Sagimet Biosciences Inc.
18 Apr 24
Definitive proxy
6:16am
. Mr. Walbert was a previous board member of the Biotechnology Innovation Organization, the Pharmaceutical Research and Manufacturing Association … , the Illinois Biotechnology Innovation Organization and World Business Chicago. Mr. Walbert received a Bachelor of Arts in business from Muhlenberg
10-K
pjuv08o
25 Mar 24
Annual report
6:37am
8-K
gxn2no2mn
25 Mar 24
Sagimet Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates
6:19am
DRS
2ebo38ku
10 Jan 24
Draft registration statement
12:00am
10-Q
xcc5s91cvmz54ewk
21 Aug 23
Quarterly report
4:05pm
424B4
qvrjsejq
14 Jul 23
Prospectus supplement with pricing info
6:56pm
DRS/A
6by1xx
11 May 23
Draft registration statement (amended)
12:00am
DRS/A
dosmjjv1huo9ec
25 Apr 23
Draft registration statement (amended)
12:00am
S-1
0i3hat 30ks0f
16 Apr 21
IPO registration
4:31pm
DRS
mqs868b 9z9
11 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next